Cointime

Neos Therapeutics

company

About

Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.

  • 101 - 250

Highlights

Total Funding Amount
$35.50M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$20M
Industries
Biotechnology,Life Science,Medical,Therapeutics
Founded date
Jan 1, 2008
Number Of Employee
101 - 250
Operating Status
Active

The Neos Therapeutics team is dedicated to creating high-quality products and partnering with pharmaceutical and consumer healthcare companies to address key medical needs.

Neos Therapeutics’ research and development (R&D) and fully integrated state of the art, FDA approved manufacturing facility is located in the Dallas/Fort Worth area.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$35.50M
Neos Therapeutics has raised a total of $35.50M in funding over 2 rounds. Their latest funding was raised on Apr 23, 2014 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 23, 2014 Debt Financing $20M 1 — — Detail
Mar 4, 2014 Series C $15.50M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
Neos Therapeutics is funded by 2 investors. Hercules Capital and Crabtree Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital — Debt Financing
Crabtree Partners — Series C
Cointime
เนื้อหา
บริษัท